Significant shareholder support for CFR’s R12,6bn acquisition of Adcock Ingram10/30/2013 12:00:00 AM
In a cautionary renewal released on the JSE’s SENS today, shareholders and the market were informed that CFR Pharmaceuticals of Chile continues to make good progress with its plans to acquire Adcock Ingram (“Adcock”) for R12,6 billion (US$1,3 billion).
Adcock Ingram Saving the Earth by Using the Earth9/17/2013 12:00:00 AM
Adcock Ingram’s liquid facility in Clayville extends across 50,000m2 of well-developed industrial land and is set up to produce over 12 million litres of oral liquid medication every year. The plant features advanced automated manufacturing and hi-tech, high-speed mechanised lines of the best quality. Perhaps the most laudable aspect of the plant is its innovative use of green technologies which have significantly reduced power consumption, costs, and the company’s carbon footprint.
Adcock Ingram and CFR reach agreement regarding the proposed creation of a uniquely diversified emerging markets pharmaceuticals company9/11/2013 12:00:00 AM
Adcock Ingram and CFR have entered into a transaction implementation agreement regarding a potential cash and shares offer by CFR to acquire 100% of the issued ordinary share capital of Adcock Ingram
New Executive Appointment at Adcock Ingram8/29/2013 12:00:00 AM
Craig St John Ayre has joined Adcock Ingram as the Commercial Executive – Business Intelligence.
Adcock Ingram Fire-Fighters to compete in national finals of competition8/19/2013 12:00:00 AM
Adcock Ingram Healthcare has gained two places in the National Finals of the Mutual Risk Group (MRG) Fire Competition to be held later this year
Adcock Ingram Enters Into Discussions With CFR Pharmaceuticals To Create A Leading Global Emerging Markets Pharmaceuticals Company7/3/2013 12:00:00 AM
The Independent Board of Adcock Ingram today announced that it has entered into discussions with CFR Pharmaceuticals S.A. (CFR) – a multinational emerging markets pharmaceutical company based in Chile – that may lead to CFR making a cash and share offer to acquire 100% of Adcock’s entire share capital. The transaction, if implemented, would create a merged company with combined revenues of approximately US$1.3 billion (approximately ZAR12.1 billion).
19 Western Cape children given the gift of a smile6/17/2013 12:00:00 AM
Children from disadvantaged backgrounds to receive facial reconstructive surgery free of charge during Adcock Ingram Smile Week
New Executive Appointments at Adcock Ingram6/13/2013 12:00:00 AM
Adcock Ingram has recently restructured its management profile with two new additions to the leadership team. Werner van Rensberg has been appointed as the new Chief Operations Officer, and Doreen Kosi as the new Government Relations Executive.
Adcock Ingram Reports Improved Trading Performance Despite Difficult Market Conditions6/4/2013 12:00:00 AM
Adcock Ingram today announced its results for the six month period ended 31 March 2013.
Adcock Ingram Receives FDA Accreditation For Its Wadeville Manufacturing Facility3/28/2013 12:00:00 AM
Adcock Ingram today announced that the Centre for Drug Evaluation and Research of the US Food and Drug Administration (FDA) has accredited the company’s Wadeville Manufacturing facility, located in Germiston, East of Johannesburg. Adcock’s Wadeville pharmaceutical facility is also certified by the Medicines Control Council (MCC) of South Africa as a current Good Manufacturing Practice facility.
Adcock Ingram Close Indian Acquisition1/18/2013 12:00:00 AM
Adcock Ingram today announced the completion of the acquisition of Cosme Farma Laboratories Limited, a pan-Indian pharmaceutical company based in Goa, India for R745 million.